Mark Packer, ESCRS 2019 – What’s next in refractive surgery?

Mark Packer talks about the latest innovations and technologies in the field of refractive surgery at ESCRS 2019.

Questions:
1. What are the main limitations of the currently available intraocular lenses (IOLS)? (0:04)
2. What are the latest innovations in this field? (2:53)
3. Could you tell us about the latest technologies in refractive surgery? (5:42)

Support: No funding was received in the production of this video.
Disclosures: Mark Packer has the following disclosures to declare: Advanced Vision Science (Santen) – Consultant, Aerie Pharmaceuticals – Investor, Alcon Research – Consultant, Bausch Health – Consultant, Cassini Technologies – Consultant and Investor, ClearSight – Consultant and Investor, International Bio Medical Devices – Consultant and Investor, Ira – Consultant and Investor, Keranova – Consultant, Lensar – Consultant, Lensgen – Consultant and Investor, Promedica International – Consultant, Precision for Medicine – Consultant, Rayner Intraocular Lenses – Consultant, Refocus Group – Consultant and Investor, SOLX – Consultant, STAAR Surgical – Consultant and Investor, Transcend Medical – Investor, TrueVision Investor, University of Colorado -Consultant, Visant Medical – Consultant and Investor, WaveTec – Investor